BioCentury
ARTICLE | Finance

Biology on the mind

How the Dementia Discovery Fund plans to find new neurodegeneration solutions

March 23, 2017 7:08 PM UTC

Less than a year and a half after its launch, the Dementia Discovery Fund has spawned four new companies and invested almost 10% of the roughly $100 million it raised in 2015. With a goal of pushing forward new therapeutics that go beyond the amyloid hypothesis, the firm believes it can make enough small bets in enough new areas to kick-start discovery in Alzheimer’s disease.

On March 15, DDF announced its latest seed investment with a £400,000 ($496,760) commitment to Autifony Therapeutics Ltd., a hearing loss company whose platform could have overlapping biology with neurodegenerative diseases such as Alzheimer’s disease. ...